Catheter Precision
VTAK
9 hedge funds and large institutions have $470K invested in Catheter Precision in 2022 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 14 closing their positions.
61% more capital invested
Capital invested by funds: $292K → $470K (+$178K)
0.02% more ownership
Funds ownership: 0% → 0.02% (+0.02%)
47% less funds holding
Funds holding: 17 → 9 (-8)
57% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 14
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$80.4K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$74.6K |
| 3 |
Goldman Sachs
New York
|
+$67.1K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$52.2K |
| 5 |
Morgan Stanley
New York
|
+$34.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SWM
Spire Wealth Management
Mclean,
Virginia
|
-$125K |
| 2 |
WA
WealthTrust Axiom
Wayne,
Pennsylvania
|
-$39K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$27K |
| 4 |
SSG
Summit Securities Group
New York
|
-$24K |
| 5 |
HF
HRT Financial
New York
|
-$16K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
State Street
Boston,
Massachusetts
| – | -$1K | -1 | Closed |
|
VTAK Hedge Fund Activity: Q4 2022 in Review
9 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Catheter Precision (VTAK) for Q4 2022, worth a combined $470K — up 61% from $292K a quarter earlier.
Sellers outnumbered buyers: 14 funds closed out of VTAK and 6 opened new positions — a net loss of 8 holders — while 0 trimmed existing stakes and 1 added.
The largest buyer was BlackRock, opening a new position worth an estimated $80.4K. The largest seller was Spire Wealth Management, exiting entirely with an estimated $125K sold.
- 9 institutional investors held Catheter Precision (VTAK) as of Q4 2022, down from 17 in Q3 2022.
- Funds reported $470K of Catheter Precision stock for Q4 2022, up 61% quarter-over-quarter.
- 6 funds opened new Catheter Precision positions in Q4 2022 and 14 closed out, a net change of -8 holders.
- The largest Catheter Precision buyer in Q4 2022 was BlackRock, an estimated $80.4K added.
- The largest Catheter Precision seller in Q4 2022 was Spire Wealth Management, an estimated $125K sold.
Based on aggregated 13F filings for Q4 2022.